Ledger.Open graph →
SEC Form D · filed February 7, 2022

Endeavor Biomedicines, Inc

Offering
$101.0M
Sold
$89.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Roger Richer · Vancouver, British Columbia, CanadaDirectorWing C. Lam · San Diego, CADirectorPatrick G. Enright · San Diego, CADirectorAlex Ruggieri · Vancouver, British Columbia, CanadaDirectorRaghu Saripalli · San Diego, CAExecKeli M. Callaghan · Miami, FLDirectorMonal C. Mehta · San Diego, CADirectorAndrew C. Hakim · GRAND RAPIDS, MIExec · DirectorRaghu Saripalli · San Diego, CAExecMiguel De Los Rios · San Diego, CAExecTodd Underwood · Portland, ORExecTaryn M. Naidu · Miami, FLExecPhilip Dickie · Grand Cayman, Cayman IslandsDirectorMatthew P. Franz · GRAND RAPIDS, MIDirectorBhavik M. Patel · Miami, FLDirectorJonathan Gazdak · Tampa, FLDirectorJohn Hood · San Diego, CAExec · DirectorBernard Davitian · San Diego, CADirectorDaniel H. Shuart · GRAND RAPIDS, MIDirectorFrancis Macdonald · Vancouver, British Columbia, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗